1. Home
  2. EHI vs CNTB Comparison

EHI vs CNTB Comparison

Compare EHI & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Global High Income Fund Inc

EHI

Western Asset Global High Income Fund Inc

SELL

Current Price

$5.35

Market Cap

163.9M

Sector

Finance

ML Signal

SELL

Logo Connect Biopharma Holdings Limited

CNTB

Connect Biopharma Holdings Limited

HOLD

Current Price

$0.90

Market Cap

140.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EHI
CNTB
Founded
N/A
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
163.9M
140.4M
IPO Year
2003
2020

Fundamental Metrics

Financial Performance
Metric
EHI
CNTB
Price
$5.35
$0.90
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $5.88
AVG Volume (30 Days)
136.4K
★ 1.6M
Earning Date
01-01-0001
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $64,000.00
Revenue This Year
N/A
$11,291.47
Revenue Next Year
N/A
$74.30
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$5.27
$0.85
52 Week High
$6.55
$3.82

Technical Indicators

Market Signals
Indicator
EHI
CNTB
Relative Strength Index (RSI) 38.06 38.38
Support Level $5.35 $0.85
Resistance Level $5.50 $2.74
Average True Range (ATR) 0.07 0.08
MACD 0.01 0.03
Stochastic Oscillator 36.74 3.46

Price Performance

Historical Comparison
EHI
CNTB

About EHI Western Asset Global High Income Fund Inc

Western Asset Global High Inc Fd Inc is a non-diversified, closed-end management investment company. Its investment objective is high current income. The Fund's secondary investment objective is total return. It invests in an international portfolio of securities consisting of below-investment-grade fixed income securities, emerging market fixed income securities, and investment-grade fixed income securities. The Fund's investment portfolio comprises sovereign bonds, collateralized mortgage obligations, asset-backed securities, and fixed income securities from different corporate sectors, including financials, energy, consumer discretionary, and industrials, among others.

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.

Share on Social Networks: